Cargando…

Application of deep learning to understand resilience to Alzheimer's disease pathology

People who have Alzheimer's disease neuropathologic change (ADNC) typically associated with dementia but not the associated cognitive decline can be considered to be “resilient” to the effects of ADNC. We have previously reported lower neocortical levels of hyperphosphorylated tau (pTau) and le...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Cecilia S., Latimer, Caitlin S., Henriksen, Jonathan C., Blazes, Marian, Larson, Eric B., Crane, Paul K., Keene, C. Dirk, Lee, Aaron Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549025/
https://www.ncbi.nlm.nih.gov/pubmed/34009663
http://dx.doi.org/10.1111/bpa.12974
_version_ 1784590704918396928
author Lee, Cecilia S.
Latimer, Caitlin S.
Henriksen, Jonathan C.
Blazes, Marian
Larson, Eric B.
Crane, Paul K.
Keene, C. Dirk
Lee, Aaron Y.
author_facet Lee, Cecilia S.
Latimer, Caitlin S.
Henriksen, Jonathan C.
Blazes, Marian
Larson, Eric B.
Crane, Paul K.
Keene, C. Dirk
Lee, Aaron Y.
author_sort Lee, Cecilia S.
collection PubMed
description People who have Alzheimer's disease neuropathologic change (ADNC) typically associated with dementia but not the associated cognitive decline can be considered to be “resilient” to the effects of ADNC. We have previously reported lower neocortical levels of hyperphosphorylated tau (pTau) and less limbic‐predominant age‐related TDP‐43 encephalopathy neuropathologic change (LATE‐NC) in the resilient participants compared to those with dementia and similar ADNC as determined by current NIA‐AA recommendations using traditional semi‐quantitative assessments of amyloid β and pathological tau burden. To better understand differences between AD‐dementia and resilient participants, we developed and applied a deep learning approach to analyze the neuropathology of 14 brain donors from the Adult Changes in Thought study, including seven stringently defined resilient participants and seven age‐matched AD‐dementia controls. We created two novel, fully automated deep learning algorithms to quantify the level of phosphorylated TDP‐43 (pTDP‐43) and pTau in whole slide imaging. The models performed better than traditional techniques for quantifying pTDP‐43 and pTau. The second model was able to segment lesions staining for pTau into neurofibrillary tangles (NFTs) and tau neurites (neuronal processes positive for pTau). Both groups had similar quantities of pTau localizing to neurites, but the pTau burden associated with NFTs in the resilient group was significantly lower compared to the group with dementia. These results validate use of deep learning approaches to quantify clinically relevant microscopic characteristics from neuropathology workups. These results also suggest that the burden of NFTs is more strongly associated with cognitive impairment than the more diffuse neuritic tau commonly seen with tangle pathology and suggest that additional factors may underlie resilience mechanisms defined by traditional means.
format Online
Article
Text
id pubmed-8549025
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85490252021-11-04 Application of deep learning to understand resilience to Alzheimer's disease pathology Lee, Cecilia S. Latimer, Caitlin S. Henriksen, Jonathan C. Blazes, Marian Larson, Eric B. Crane, Paul K. Keene, C. Dirk Lee, Aaron Y. Brain Pathol Research Articles People who have Alzheimer's disease neuropathologic change (ADNC) typically associated with dementia but not the associated cognitive decline can be considered to be “resilient” to the effects of ADNC. We have previously reported lower neocortical levels of hyperphosphorylated tau (pTau) and less limbic‐predominant age‐related TDP‐43 encephalopathy neuropathologic change (LATE‐NC) in the resilient participants compared to those with dementia and similar ADNC as determined by current NIA‐AA recommendations using traditional semi‐quantitative assessments of amyloid β and pathological tau burden. To better understand differences between AD‐dementia and resilient participants, we developed and applied a deep learning approach to analyze the neuropathology of 14 brain donors from the Adult Changes in Thought study, including seven stringently defined resilient participants and seven age‐matched AD‐dementia controls. We created two novel, fully automated deep learning algorithms to quantify the level of phosphorylated TDP‐43 (pTDP‐43) and pTau in whole slide imaging. The models performed better than traditional techniques for quantifying pTDP‐43 and pTau. The second model was able to segment lesions staining for pTau into neurofibrillary tangles (NFTs) and tau neurites (neuronal processes positive for pTau). Both groups had similar quantities of pTau localizing to neurites, but the pTau burden associated with NFTs in the resilient group was significantly lower compared to the group with dementia. These results validate use of deep learning approaches to quantify clinically relevant microscopic characteristics from neuropathology workups. These results also suggest that the burden of NFTs is more strongly associated with cognitive impairment than the more diffuse neuritic tau commonly seen with tangle pathology and suggest that additional factors may underlie resilience mechanisms defined by traditional means. John Wiley and Sons Inc. 2021-05-19 /pmc/articles/PMC8549025/ /pubmed/34009663 http://dx.doi.org/10.1111/bpa.12974 Text en © 2021 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Lee, Cecilia S.
Latimer, Caitlin S.
Henriksen, Jonathan C.
Blazes, Marian
Larson, Eric B.
Crane, Paul K.
Keene, C. Dirk
Lee, Aaron Y.
Application of deep learning to understand resilience to Alzheimer's disease pathology
title Application of deep learning to understand resilience to Alzheimer's disease pathology
title_full Application of deep learning to understand resilience to Alzheimer's disease pathology
title_fullStr Application of deep learning to understand resilience to Alzheimer's disease pathology
title_full_unstemmed Application of deep learning to understand resilience to Alzheimer's disease pathology
title_short Application of deep learning to understand resilience to Alzheimer's disease pathology
title_sort application of deep learning to understand resilience to alzheimer's disease pathology
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549025/
https://www.ncbi.nlm.nih.gov/pubmed/34009663
http://dx.doi.org/10.1111/bpa.12974
work_keys_str_mv AT leececilias applicationofdeeplearningtounderstandresiliencetoalzheimersdiseasepathology
AT latimercaitlins applicationofdeeplearningtounderstandresiliencetoalzheimersdiseasepathology
AT henriksenjonathanc applicationofdeeplearningtounderstandresiliencetoalzheimersdiseasepathology
AT blazesmarian applicationofdeeplearningtounderstandresiliencetoalzheimersdiseasepathology
AT larsonericb applicationofdeeplearningtounderstandresiliencetoalzheimersdiseasepathology
AT cranepaulk applicationofdeeplearningtounderstandresiliencetoalzheimersdiseasepathology
AT keenecdirk applicationofdeeplearningtounderstandresiliencetoalzheimersdiseasepathology
AT leeaarony applicationofdeeplearningtounderstandresiliencetoalzheimersdiseasepathology